YOLFTbeta
Chi Sheng Chemical

Chi Sheng Chemical

4111 · TWO · Healthcare / Medical Instruments & Supplies

28.55TWD-0.05 (-0.17%)

Price History

Full chart

Market Stats

Previous Close28.60
Open28.50
Day Range28.45 – 28.55
52-Week Range28.40 – 30.95
Volume16.39K
Market Cap1.74B
P/E (TTM)9.24
Forward P/E26.60
EPS3.14
Dividend Yield4.48%
Beta0.20
50-Day Avg29.28
200-Day Avg29.63

About

Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and anti-asthmatics; gastro-intestinal preparations; local anesthetic preparations; hemodialysis concentrate and external solutions; peritoneal dialysis solutions; and others. The company also offers medical devices, fat emulsion products, anesthetic products, hemostatic solutions, food and health food products, functional drinks, skin care products and cosmetics, and veterinary medicinal products. In addition, it provides externally applied medicines, including contact lens, and salt and iodine solutions. Chi Sheng Pharma & Biotech Co., Ltd was founded in 1962 and is headquartered in Hukou, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEODongmao Su
  • Employees0
  • HeadquartersNo. 3, Shih Chen Road, Hukou, Taiwan, 30352, Taiwan
  • Websitehttps://www.cscp.com.tw

Leadership

  • Dongmao SuChairman & GM
  • Hui-Zhen HuangFinance Manager & Accounting Supervisor
  • Li Zhu WeiVice President of Technology & Plant Manager
  • Guo Ping XieBrand Marketing Manager

Financials

Income Statement

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.04B967.40M1.02B979.36M1.02B1.14B1.06B1.17B1.38B
Growth (%)--7.38%+5.74%-4.26%+4.38%+11.81%-7.19%+9.86%+18.11%
Cost of Revenue698.81M673.54M682.76M656.43M665.72M720.57M717.76M768.25M832.82M
Gross Profit345.73M293.86M340.20M322.92M356.58M422.51M343.10M397.18M543.66M
Gross Margin33.10%30.38%33.26%32.97%34.88%36.96%32.34%34.08%39.50%
Operating Expense242.40M251.09M242.72M241.33M223.71M258.70M281.89M298.24M344.35M
Operating Income103.32M42.76M97.47M81.60M132.87M163.81M61.21M98.95M199.32M
Operating Margin9.89%4.42%9.53%8.33%13.00%14.33%5.77%8.49%14.48%
EBITDA173.60M136.00M180.00M165.74M211.95M236.68M150.75M205.74M281.57M
EBITDA Margin16.62%14.06%17.60%16.92%20.73%20.71%14.21%17.65%20.46%
Net Income81.74M42.25M72.45M59.14M80.75M154.01M68.67M110.63M164.28M
Net Income Margin7.83%4.37%7.08%6.04%7.90%13.47%6.47%9.49%11.93%
R&D23.04M22.53M20.64M18.21M18.93M19.69M21.67M18.00M16.51M
R&D as % of Total Revenue2.21%2.33%2.02%1.86%1.85%1.72%2.04%1.54%1.20%
Interest Expense0411.00K263.00K162.00K1.09M1.52M1.46M1.74M517.00K
Interest Expense % of Total Revenue0.00%0.04%0.03%0.02%0.11%0.13%0.14%0.15%0.04%

Balance Sheet

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.48B1.50B1.52B1.49B1.66B1.80B1.77B1.75B1.94B
Total Liabilities428.39M458.24M450.25M410.93M559.04M578.38M547.04M475.08M557.04M
Total Equity1.05B1.05B1.07B1.08B1.10B1.22B1.22B1.27B1.38B
Cash205.30M226.01M275.20M335.80M252.27M456.25M381.05M336.19M443.91M
Total Debt--172.75M148.56M292.20M290.38M---
Net Debt---102.44M-187.24M39.93M-165.88M---

Cash Flow

Currency: TWD2002-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-181.14M114.19M162.96M143.53M139.33M214.86M74.52M213.20M274.61M
Investing Cash Flow--47.50M-78.36M-36.67M-20.56M-289.02M----
Financing Cash Flow--45.48M-10.56M-73.91M-63.43M66.68M-74.88M---
Capital Expenditure046.79M75.36M36.90M22.79M265.51M105.85M102.00M85.22M94.54M
Free Cash Flow-132.94M37.52M126.06M120.74M-126.18M109.00M-27.48M127.98M180.07M
Dividends Paid-45.59M45.59M34.19M56.98M56.98M56.98M68.38M56.98M56.98M
FCF to OCF-73.39%32.85%77.36%84.12%-90.57%50.73%-36.87%60.03%65.57%
Dividend Paid to FCF-34.29%121.51%27.12%47.19%-45.16%52.28%-248.87%44.53%31.65%

Earnings

Report DateMar 31, 2003Mar 31, 2006Jun 30, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 12, 2014Nov 12, 2014Feb 25, 2015May 14, 2015Aug 13, 2015Nov 12, 2015Mar 30, 2016May 10, 2016Aug 4, 2016Nov 4, 2016Mar 31, 2017May 8, 2017Aug 7, 2017Nov 14, 2017Mar 20, 2018May 8, 2018Aug 15, 2018Nov 14, 2018Feb 27, 2019Apr 2, 2019Aug 6, 2019Nov 6, 2019Mar 24, 2020May 6, 2020Aug 5, 2020Nov 5, 2020Mar 24, 2021May 6, 2021Aug 5, 2021Nov 3, 2021Mar 16, 2022May 5, 2022Aug 5, 2022Nov 4, 2022Mar 24, 2023May 3, 2023
EPS Estimate--------------------------0.460.61-0.220.320.46-------0.410.46-------0.210.26----------0.54-
EPS Actual0.080.140.110.160.080.050.120.100.220.230.100.050.220.110.060.090.180.400.330.290.220.180.390.510.600.360.360.470.050.110.210.300.030.160.290.370.450.380.340.400.280.170.180.280.110.240.370.290.380.450.280.140.150.220.210.390.590.460.460.820.900.33
Surprise---------------------------21.74%-22.95%--50.00%-34.38%-34.78%--------2.44%-39.13%-------80.95%73.08%----------66.67%-
Timing--------------------------After-hoursPre-market-After-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hours-After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.74B
Enterprise Value1.30B
Trailing P/E9.24
Forward P/E26.60
Price / Sales1.22
Price / Book1.23
EPS3.14
Book Value23.42
Revenue (TTM)1.42B
Gross Profit (TTM)559.75M
EBITDA276.79M
Profit Margin13.31%
Operating Margin13.84%
Return on Equity14.05%
Return on Assets6.58%
Shares Outstanding59.83M
Shares Float46.13M
Beta0.20
Dividend Yield4.48%
Dividend Rate1.30
Payout Ratio31.82%

Dividends

20261×
1.30Aug 25, 2026
20251×
1.00Aug 26, 2025
20241×
0.95Aug 23, 2024
20231×
1.14Aug 22, 2023
20221×
0.95Aug 22, 2022
20211×
0.95Aug 20, 2021
20201×
0.95Aug 20, 2020
20191×
0.57Aug 22, 2019
20181×
0.76Aug 23, 2018
20171×
0.76Sep 4, 2017
20161×
0.57Aug 23, 2016
20151×
0.38Sep 17, 2015
20141×
0.44Aug 28, 2014
20131×
0.34Sep 4, 2013
20121×
0.29Jul 16, 2012
20111×
0.25Sep 1, 2011
20101×
0.24Sep 2, 2010
20091×
0.37Aug 19, 2009
20081×
0.32Jul 2, 2008

Stock Splits

  • Aug 26, 20251050:1000
  • Sep 17, 20151040:1000
  • Aug 28, 20141050:1000
  • Sep 4, 20131.04:1
  • Sep 1, 20111.02:1
  • Sep 2, 20101025:1000
  • Aug 19, 2009100.3:100